Sign in

CIK 0001531177

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sight Sciences, Inc.

Sign in to watch
Ticker
SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800625749
Phone
+1 415-889-0550
Business address
4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
  1. 4 Open-market sale Chief Financial Officer sold 4,999 shares at an average $7.78 ($38,890)
  2. 4 Open-market sale Chief Operating Officer sold 20,543 shares at an average $7.66 ($157,366)
  3. 4 Open-market sale EVP, Operations & R&D sold 619 shares at $7.48 ($4,630)
  4. 4 Option exercise Chief Technology Officer acquired 21,270 shares (option exercise)
  5. 4/A Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 13,958 shares at $8.31 ($115,963)
  7. 4 Open-market sale Chief Financial Officer sold 2,518 shares at $8.25 ($20,774)
  8. 4 Planned sale Chief Legal Officer sold 44,850 shares at $8.08 ($362,388)
  9. 4 Open-market sale EVP, Operations & R&D sold 14,418 shares at $7.06 ($101,791)
  10. 4 Planned sale Chief Legal Officer sold 3,150 shares at $8.01 ($25,232)
  11. 4 Grant or award Chief Operating Officer acquired 23,006 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 15,337 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale EVP, Operations & R&D sold 591 shares at $3.37 ($1,992)
  15. 4 Open-market sale Chief Financial Officer sold 19,948 shares at $3.30 ($65,828)
  16. 4 Open-market sale President and CEO sold 24,441 shares at $3.34 ($81,633)
  17. 4 Open-market sale Chief Technology Officer sold 6,033 shares at $3.27 ($19,728)
  18. 4 Open-market sale Chief Legal Officer sold 9,731 shares at $3.27 ($31,820)
  19. 4 Gift Director gave 37,492 shares (gift)
  20. 4 Grant or award EVP, Operations & R&D acquired 25,840 shares (grant or award)

Page 3 of 12 · 225 filings